The exposome comprises all internal and external environmental factors that impact the onset, duration, and severity of a disease. To define the impact of the exposome on acne, an international study was performed in 6 countries (i.e. France, Germany, Italy, Brazil, Canada, and Russia). A total of 10,040 individuals were recruited and data from 6,679 participants was analysed (acne group n=2,826; control group n=3,853). Eligible for inclusion were acne patients who declared that their acne had been diagnosed by a physician or who had benefitted from an acne treatment prescribed by a physician. All participants filled out an online survey designed to evaluate 6 main exposome factors, climate, nutrition, and pollution.
With regard to climatic factors, acne patients lived significantly more often in a particularly hot climate (P<0.001 vs non-acne patients). A significant higher percentage of acne patients had an intense or moderate exposure to the sun in their work or daily activities. “Although sun exposure can improve acne, there are often flares after sun exposure,” explained Dr Delphine Kerob (Vichy Laboratories, France) who supported the study.
People with acne were also significantly more exposed to pollutants (i.e. tars, solvent vapours, oil vapours) than those without (P<0.001 for each comparison). Those affected by acne lived significantly more often near the airport or in an area with factories with chimneys (P<0.001 for each comparison).
Western diet aggravates acne vulgaris
Significant differences were also seen with regard to nutrition. Acne patients more often consumed cow´s milk on a daily basis (48% vs 39%, P<0.001), sodas, juices and syrups (35% vs 31%; P<0.001), baked goods, cakes, or pastries (40% vs 28%; P<0.001), chocolate (37% vs 28%; P<0.001), or sweets (23% vs 19%; P<0.001). In addition, they reported more frequently to snack on sugary foods between meals (62% vs 43% ; P<0.001). Whey proteins were consumed more often by acne patients than people without acne (11% vs 7.3%; P<0.001). This is in line with an earlier study that found a close link between acne and a western diet containing refined carbohydrates, milk and dairy products, and saturated fats. This led via multiple pathways to a Th17 activation resulting in inflammation and comedogenesis [2]. Another surprising finding was that 12% of acne patients had used an anabolic steroid or testosterone-based hormonal drug within the previous 12 months, compared with 3.2% of controls without acne.
Skincare routines can also influence acne: the use of facial scrubs, harsh cleansers, and dermarollers was significantly more common among acne patients. “A lot of patients used scrubs that can be responsible for mechanical acne,” commented Dr Kerob. Taken together, identifying and reducing the impact of the exposome is important for an adequate disease-management of acne.
- Kerob B, et al. Late-breaking abstract D3T01.1G, EADV 2019, 9-13 Oct, Madrid, Spain.
- Melnik MC. Clin Cosmet Investig Dermatol 2015;8:371-88.
Posted on
Previous Article
« JAK inhibition plus TCS lead to high clearance rates in AD Next Article
Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata »
« JAK inhibition plus TCS lead to high clearance rates in AD Next Article
Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata »
Table of Contents: EADV 2019
Featured articles
Late-Breaking News
IL-17A blocker effective in paediatric psoriasis patients
Rituximab beats mycophenolate mofetil in pemphigus vulgaris
Acne highly influenced by climate, pollutants, and unhealthy diet
JAK inhibition plus TCS lead to high clearance rates in AD
No cancer risk with long-term use of tacrolimus, a topical calcineurin inhibitor, in children with AD
Green light for a second JAK inhibitor in AD
Topical ruxolitinib effective in vitiligo
Emerging Therapies
Small molecules: interesting novel treatment options in AD
IL-1⍺ blockade: a new treatment option in AD
IL-4/IL-13 blockade leads to rapid itch reduction in adolescents
How to manage conjunctivitis in AD patients treated with a biologic
Biologics: increasingly used in paediatric dermatology
Spotlight on Psoriasis
IL-17 blocker: effective and safe in patients with comorbidities
ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker
Relationship psoriasis and NAFLD: new data on the hepato-dermal axis
Novel selective IL-23 blocker equally effective in patients with metabolic syndrome
Selective IL-23 blocker crushes fumaric acids in all assessed efficacy endpoints
No hint of teratogenicity through ixekizumab
New Insights in Photoprotection
Systemic photoprotection: a valuable addition to topical sun protection
The underestimated effect of visible light
Urticaria
Comorbidities more common in chronic urticaria, psoriasis, and AD
D-Dimer as future biomarker in CSU management?
Ligelizumab for CSU: symptom control and high response rates in re-treatment
Rosacea – From New Spectrum to New Therapy
New guidance on rosacea therapy according to phenotype
Best of the Posters
Above-the-neck melanoma more prone to metastases
Reduced sleep quality in dermatoses influenced by itch and pain
Anxiety and depression are common in families of AD infants
Certolizumab pegol efficacious for head and neck psoriasis
Related Articles
September 17, 2021
COVID-19 affects patients and care
September 17, 2021
Unresolved needs for patients with PsA despite growing therapeutic options
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com